• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颅超声检查的临床和人口统计学特征预测 PD 认知障碍:一项纵向研究。

Transcranial sonography with clinical and demographic characteristics to predict cognitive impairment in PD: a longitudinal study.

机构信息

Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.

出版信息

BMC Neurol. 2023 Jan 13;23(1):15. doi: 10.1186/s12883-023-03057-1.

DOI:10.1186/s12883-023-03057-1
PMID:36639620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9837901/
Abstract

BACKGROUND

Parkinson's disease (PD) is a neurodegenerative disease and is clinically characterized by a series of motor symptoms (MS) and nonmotor symptoms (NMS). NMS often appear before MS, while cognitive impairment mostly occurs within a few years after the diagnosis of PD. Therefore, we aimed to predict the risk factors for cognitive impairment (CI) in PD patients based on transcranial sonography, clinical symptoms, and demographic characteristics.

METHODS

Based on the occurrence time of CI, a total of 172 PD patients were divided into non-CI (N-CI, n = 48), CI at the first treatment (F-CI, n = 58), and CI at the last treatment (L-CI, n = 66) groups. Clinical data (including MS and NMS) and ultrasonic data of all patients at the first treatment and the last treatment were collected retrospectively. Independent samples t tests were used to compare continuous data, and chi-square tests were used to compare categorical data. The risk factors for CI and Parkinson's disease dementia were identified by logistic regression analysis, and an ROC curve was established to explore the diagnostic efficacy.

RESULTS

  1. The age of onset, first treatment and smoking history of CI patients were significantly different from those of N-CI patients. When age of first treatment ≥61 years was considered the boundary value to diagnose CI, the sensitivity and specificity were 77.40 and 66.70%, respectively. 2) The severity of depression was significantly different between F-CI and N-CI patients at the first treatment, while the cumulative and new or aggravated memory deficit was significantly different between the L-CI and N-CI patients at the last treatment. 3) There was a significant difference in TCS grading between the first and last treatment in L-CI patients. 4) Depression, sexual dysfunction, and olfactory dysfunction in NMS were independent risk factors for CI during the last treatment. 5) The sensitivity and specificity of predicting CI in PD patients were 81.80 and 64.60%, respectively.

CONCLUSIONS

PD patients with CI were older, and most of them had a history of smoking. Furthermore, there was good diagnostic efficiency for predicting CI in PD via TCS combined with clinical characteristics (especially NMS).

摘要

背景

帕金森病(PD)是一种神经退行性疾病,临床上以一系列运动症状(MS)和非运动症状(NMS)为特征。NMS 通常在 MS 之前出现,而认知障碍大多在 PD 诊断后几年内发生。因此,我们旨在基于经颅超声、临床症状和人口统计学特征预测 PD 患者认知障碍(CI)的危险因素。

方法

根据 CI 的发生时间,将 172 例 PD 患者分为非 CI(N-CI,n=48)、首次治疗时 CI(F-CI,n=58)和末次治疗时 CI(L-CI,n=66)组。回顾性收集所有患者首次和末次治疗时的临床数据(包括 MS 和 NMS)和超声数据。采用独立样本 t 检验比较连续数据,采用卡方检验比较分类数据。采用逻辑回归分析识别 CI 和帕金森病痴呆的危险因素,并绘制 ROC 曲线探讨诊断效能。

结果

1)CI 患者的发病年龄、首次治疗和吸烟史与 N-CI 患者明显不同。当首次治疗年龄≥61 岁作为诊断 CI 的界值时,其灵敏度和特异度分别为 77.40%和 66.70%。2)首次治疗时 F-CI 患者与 N-CI 患者的抑郁严重程度明显不同,末次治疗时 L-CI 患者与 N-CI 患者的累积和新的或加重的记忆缺陷明显不同。3)末次治疗时 L-CI 患者 TCS 分级在首次和末次治疗之间有显著差异。4)NMS 中的抑郁、性功能障碍和嗅觉功能障碍是非运动症状末次治疗时 CI 的独立危险因素。5)TCS 联合临床特征(尤其是 NMS)对 PD 患者 CI 的预测灵敏度和特异度分别为 81.80%和 64.60%。

结论

PD 患者 CI 发生时年龄较大,大多数有吸烟史。此外,经颅超声结合临床特征(尤其是 NMS)预测 PD 患者 CI 具有良好的诊断效率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/ad14a0096606/12883_2023_3057_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/e8792afc0547/12883_2023_3057_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/0f23e2fa6972/12883_2023_3057_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/e7731fc28352/12883_2023_3057_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/629e8b9af3b2/12883_2023_3057_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/1d7c0c3cf9c5/12883_2023_3057_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/ad14a0096606/12883_2023_3057_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/e8792afc0547/12883_2023_3057_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/0f23e2fa6972/12883_2023_3057_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/e7731fc28352/12883_2023_3057_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/629e8b9af3b2/12883_2023_3057_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/1d7c0c3cf9c5/12883_2023_3057_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d925/9837901/ad14a0096606/12883_2023_3057_Fig6_HTML.jpg

相似文献

1
Transcranial sonography with clinical and demographic characteristics to predict cognitive impairment in PD: a longitudinal study.经颅超声检查的临床和人口统计学特征预测 PD 认知障碍:一项纵向研究。
BMC Neurol. 2023 Jan 13;23(1):15. doi: 10.1186/s12883-023-03057-1.
2
Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.平衡步态障碍作为帕金森病患者认知障碍、痴呆和相关非运动症状的危险因素的重要性。
J Parkinsons Dis. 2018;8(4):539-552. doi: 10.3233/JPD-181375.
3
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's disease.非运动症状负担分级可预测帕金森病患者的认知障碍。
Brain Behav. 2021 May;11(5):e02086. doi: 10.1002/brb3.2086. Epub 2021 Mar 1.
4
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.帕金森病的非运动症状与自然史:来自认知功能障碍的证据及非侵入性干预的作用
Int Rev Neurobiol. 2017;133:389-415. doi: 10.1016/bs.irn.2017.05.031. Epub 2017 Jul 13.
5
Association of cognitive activities of daily living (ADL) function and nonmotor burden in nondemented Parkinson's disease patients.非痴呆型帕金森病患者日常生活认知活动功能与非运动性负担的相关性。
Neuropsychology. 2020 May;34(4):447-455. doi: 10.1037/neu0000627. Epub 2020 Mar 19.
6
Association between falls and nonmotor symptoms in patients with Parkinson's disease.帕金森病患者跌倒与非运动症状的相关性。
J Clin Neurosci. 2023 Dec;118:143-146. doi: 10.1016/j.jocn.2023.10.013. Epub 2023 Nov 6.
7
Third ventricular width by transcranial sonography is associated with cognitive impairment in Parkinson's disease.经颅超声测量第三脑室宽度与帕金森病患者的认知障碍相关。
CNS Neurosci Ther. 2024 Feb;30(2):e14360. doi: 10.1111/cns.14360. Epub 2023 Jul 13.
8
The Epidemiology of Nonmotor Symptoms in Parkinson's Disease (Cohort and Other Studies).帕金森病非运动症状的流行病学(队列研究及其他研究)
Int Rev Neurobiol. 2017;133:91-110. doi: 10.1016/bs.irn.2017.05.012. Epub 2017 Jun 27.
9
Third ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's disease.经颅超声测量的第三脑室宽度与帕金森病患者的认知表现相关。
Parkinsonism Relat Disord. 2019 Sep;66:68-73. doi: 10.1016/j.parkreldis.2019.07.005. Epub 2019 Jul 7.
10
Specificity of transcranial sonography in parkinson spectrum disorders in comparison to degenerative cognitive syndromes.经颅超声在帕金森综合征与退行性认知综合征中的特异性比较。
BMC Neurol. 2012 Mar 8;12:12. doi: 10.1186/1471-2377-12-12.

引用本文的文献

1
A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease.基于神经元特异性烯醇化酶和黑质高回声性的列线图用于识别帕金森病中的认知障碍。
Quant Imaging Med Surg. 2024 May 1;14(5):3581-3592. doi: 10.21037/qims-23-1778. Epub 2024 Apr 11.

本文引用的文献

1
Interpersonal Psychotherapy for Depression in Parkinson's Disease: A Feasibility Study.帕金森病抑郁的人际心理治疗:一项可行性研究。
J Geriatr Psychiatry Neurol. 2023 Jan;36(1):52-62. doi: 10.1177/08919887221090220. Epub 2022 Apr 21.
2
Coffee, smoking and aspirin are associated with age at onset in idiopathic Parkinson's disease.咖啡、吸烟和阿司匹林与特发性帕金森病的发病年龄有关。
J Neurol. 2022 Aug;269(8):4195-4203. doi: 10.1007/s00415-022-11041-x. Epub 2022 Mar 2.
3
Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease.
酚酸类物质与认知能力下降的预防:具有神经保护作用的多酚类物质与认知障碍和阿尔茨海默病。
Nutrients. 2022 Feb 15;14(4):819. doi: 10.3390/nu14040819.
4
Neurophysiological Aspects of REM Sleep Behavior Disorder (RBD): A Narrative Review.快速眼动睡眠行为障碍(RBD)的神经生理学方面:一项叙述性综述。
Brain Sci. 2021 Nov 30;11(12):1588. doi: 10.3390/brainsci11121588.
5
An unusual gait disorder at the Emergency Department: role of the quantitative assessment of parenchymal transcranial Doppler sonography.急诊科的一种罕见步态障碍:实质经颅多普勒超声定量评估的作用
Quant Imaging Med Surg. 2021 May;11(5):2195-2200. doi: 10.21037/qims-20-982.
6
Substantia Nigra Hyperechogenicity Reflects the Progression of Dopaminergic Neurodegeneration in 6-OHDA Rat Model of Parkinson's Disease.黑质高回声反映帕金森病6-羟多巴胺大鼠模型中多巴胺能神经变性的进展。
Front Cell Neurosci. 2020 Aug 4;14:216. doi: 10.3389/fncel.2020.00216. eCollection 2020.
7
Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem.帕金森病患者的性功能障碍:一项多中心意大利横断面研究,关注仍被忽视的问题。
J Sex Med. 2020 Oct;17(10):1914-1925. doi: 10.1016/j.jsxm.2020.06.010. Epub 2020 Jul 11.
8
Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update.乙酰左旋肉碱治疗痴呆和其他认知障碍:关键性更新。
Nutrients. 2020 May 12;12(5):1389. doi: 10.3390/nu12051389.
9
Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.帕金森病中黑质高回声与铁沉积的共定位分析:一项经颅超声与磁共振成像的多模态图谱研究
Neuroimage Clin. 2020;26:102185. doi: 10.1016/j.nicl.2020.102185. Epub 2020 Feb 1.
10
Transcranial Doppler ultrasound in vascular cognitive impairment-no dementia.经颅多普勒超声在血管性认知障碍但非痴呆中的应用。
PLoS One. 2019 Apr 24;14(4):e0216162. doi: 10.1371/journal.pone.0216162. eCollection 2019.